UNSPSC 51282915: Ecenofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H21FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3613ZY362L, chemically known as 1,8-naphthyridine-3-carboxylic acid, 7-((1r,5s,6s)-6-amino-1-methyl-3-azabicyclo(3.2.0)hept-3-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, rel-( )- but generally known as ecenofloxacin, which bears US NIH Compound Identifier 178066.

UNSPSC 51282915 Ecenofloxacin, a Commodity code, shows limited recent activity directly aligned with its nominal scope. The three recent state and local opportunities tagged to this code involve naloxone and safe drug deactivation systems procurement (Seminole County, Florida), a therapeutic pharmacy initiative request for information (Texas Health and Human Services Commission), generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance), and medical and first aid supplies for emergency response (City of Tampa). Of these, only the Seminole County and City of Tampa solicitations involve tangible product procurement with defined scope and response dates; the Texas HHS RFI and Minnesota MMCAP RFP address broader pharmacy benefit programs and generic pharmaceutical distribution networks rather than ecenofloxacin specifically. The issuing bodies include a county health program, a state health commission, a multi-state cooperative purchasing alliance, and a municipal fire department, reflecting fragmentation across health departments, emergency services, and cooperative procurement vehicles. The code shows little evidence of focused procurement activity around the antibiotic ecenofloxacin itself.

Geographic activity spans Florida (Seminole County), Texas (state-level), Minnesota and Oregon (cooperative purchasing), and Florida again (Tampa), with no clear concentration in any single state or region. The most concrete recent opportunities are Seminole County's IFB 60459723LAS for 1,900 units of naloxone annually (response due July 26, 2023, though posted June 30, 2026—a date discrepancy in the source), and the City of Tampa's Bid 26-P-00145 for medical and first aid supplies including respiratory and cardiac equipment (response due March 13, 2026, with estimated contract value of $700,000.00 and designated as a sheltered market for certified Small Local Business Enterprises with a 5% bid discount). The Minnesota MMCAP RFP S1070000015802 for generic pharmaceuticals and OTC products (response due March 26, 2026) represents multi-state cooperative purchasing at scale but does not target ecenofloxacin specifically. The code's nominal scope—ecenofloxacin, a fluoroquinolone antibiotic—does not clearly map to the actual procurement activity tagged under it, suggesting either misclassification in source data or limited genuine market demand under this Commodity code in current state and local procurement.